Current advances in osteosarcoma
Author(s)
Bibliographic Information
Current advances in osteosarcoma
(Advances in experimental medicine and biology, v. 804)
Springer, c2014
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.
Table of Contents
Historical Perspective on the Introduction and Use of Chemotherapy for the Treatment of Osteosarcoma
Norman Jaffe
Wnt Signaling in Osteosarcoma
Carol H Lin, Tao Ji, Cheng-Fong Chen, Bang H Hoang
Receptor Tyrosine Kinases in Osteosarcoma: Not Just the Usual Suspects
Ashley N. Rettew, Patrick J Getty, and Edward M. Greenberg
Understanding the Role of Notch in Osteosarcoma
Madonna M McManus, Kurt R Weiss, and Dennis PM Hughes
Developmental Pathways Highjacked by Osteosarcoma
Yi Zhang, Jared R Mortus, and Dennis PM Hughes
MicroRNAs in Osteosarcomagenesis
Lisa A Kafchinski and Kevin B Jones
RECQ DNA Helicases and Osteosarcoma
Linchao Lu, Weidong Jin, Hao Liu, and Lisa L Wang
Autophagy in Osteosarcoma
Janice Santiago O'Farrill and Nancy Gordon
HER-2 Involvement in Osteosarcoma
Jonathan Gill, David Geller, and Richard Gorlick
Role of Ezrin in Osteosarcoma Metastasis
Ling Ren and Chand Khanna
Participation of the Fas/FasL Signaling Pathway and the Lung Microenvironment in the Development of Osteosarcoma Lung Metastases
Gangxiong Huang, Kazumasa Nishimoto, Yuanzheng Yang, and Eugenie S Kleinerman
Zebrafish as a Model for Human Osteosarcoma
AB Mohseny and Pancras CW Hogendoorn
Using Canine Osteosarcoma as a Model to Assess Efficacy of Novel Therapies: Can Old Dogs Teach Us New Tricks?
Carlos O Rodriguez
Oncolytic Viruses for Potential Osteosarcoma Therapy
Pooja Hingorani, Valerie Sampson, Christina Lettieri, E. Anders Kolb
IL-11R : A Novel Target for the Treatment of Osteosarcoma
Valerae Lewis
Bone-seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223
Peter M Anderson, Vivek Subbiah, and Eric Rohren
Muramyl Tripeptide-phophatidyl Ethanolamine Encapsulated in Lipomes (L-MTP-PE) in the Treatment of Osteosarcoma
Paul A Meyers
Genetically Modified T-cell Therapy for Osteosarcoma
Christopher DeRenzo and Stephen Gottschalk
Natural Killer Cells for Osteosarcoma
Nidale Tarek, and Dean A Lee.
by "Nielsen BookData"